Apyx Medical Corporation

APYXNASDAQHealthcare● Active

$4.99

+$0.22(+4.61%)

Market Cap$208951015

P/E Ratio—

52W High$4.99

52W Low$1.59

Avg Volume172K

Open$4.77

Beta1.39

Free Cash Flow Financials Revenue

Apyx Medical Corporation (APYX) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

APYX · free cash flow · updated Jun 9, 2026

Core FCF metrics

APYX · FCF · TTM · margin & CAGR

Free cash flow was −$9.1M for FY2025 (fiscal year ending 2025-12-31), up 51.4% year-over-year The FCF margin was -17.3%.

FY2025 Free Cash Flow−$9.1M▲ +51.4% YoY

Trailing 12M (TTM)−$9.0Mtrailing 4 quarters sum

FCF Margin-17.3%−$9.1M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

APYX · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$8.0M(1M)−$9.1M▲ +51.4%-17.3%

FY2024−$18.0M(1M)−$18.8M▼ 224.6%-39.0%

FY2023−$5.2M(1M)−$5.8M▲ +72.8%-11.1%

FY2022−$20.3M(1M)−$21.3M▼ 90.6%-47.8%

FY2021−$10.4M(1M)−$11.2M▲ +32.9%-23.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

APYX · P/FCF · FCF yield · FCF per share

Apyx Medical Corporation (APYX) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

APYX · cash flow statement · operating / investing / financing

For FY2025, Apyx Medical Corporation generated −$8.0M in operating cash flow and spent 1M in capital expenditures, yielding −$9.1M in free cash flow.

Operating Activities

−$8.0M

Cash from core business operations

2025-12-31

Investing Activities

−$1.1M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$9.6M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$8.0M) − |CapEx| (1M) = FCF (−$9.1M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

APYX vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Apyx Medical CorporationYOU

APYX

−$9.1M+51.4%-17.2%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Apyx Medical Corporation (APYX) reported free cash flow of −$9.1M for FY2025 (fiscal year ending 2025-12-31), up 51.4% year-over-year. The FCF margin was -17.3%.

Based on available data, Apyx Medical Corporation has maintained positive free cash flow for at least 1 fiscal year(s). FCF peaked at $1.4M in FY2011.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

APYX free cash flow · 8 questions

Apyx Medical Corporation free cash flow was −$9.1M for FY2025, up 51.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$9.0M.

APYX free cash flowAPYX FCFAPYX FCF 2025APYX free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Apyx Medical Corporation · Apyx Medical Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026